These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10752815)

  • 1. Naloxone decreases tolerance to hypotensive, hypovolemic stress healthy humans.
    Lightfoot JT; Katz L; DeBate K
    Crit Care Med; 2000 Mar; 28(3):684-91. PubMed ID: 10752815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone therapy in shock: the controversy continues.
    Napolitano LM
    Crit Care Med; 2000 Mar; 28(3):887-8. PubMed ID: 10752851
    [No Abstract]   [Full Text] [Related]  

  • 3. Presyncope during progressive hypovolaemia simulated by lower body negative pressure is not prevented by high-dose naloxone.
    Ligtenberg G; Blankestijn PJ; Koomans HA
    Nephrol Dial Transplant; 1998 Feb; 13(2):398-403. PubMed ID: 9509453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of naloxone on the increased sensitivity to propofol during hypovolemia in the rat.
    De Paepe P; Van Sassenbroeck DK; Belpaire FM; Buylaert WA
    Crit Care Med; 2001 May; 29(5):997-9. PubMed ID: 11378611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral effects of opiate antagonists in shock.
    Lefer AM; Curtis MT
    Adv Shock Res; 1983; 10():83-6. PubMed ID: 6308976
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of naloxone on hemorrhagic shock].
    Lu H; Xu G; Sheng Z
    Zhonghua Wai Ke Za Zhi; 1995 Jun; 33(6):355-8. PubMed ID: 8582220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mechanism of the action of opiate receptor antagonists in acute shock-induced blood loss].
    Sherman DM; Lafarenko VA
    Eksp Klin Farmakol; 1998; 61(1):25-9. PubMed ID: 9575407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism.
    Cozzolino D; Sasso FC; Cataldo D; Gruosso D; Giammarco A; Cavalli A; Di Maggio C; Renzo G; Salvatore T; Giugliano D; Torella R
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5167-74. PubMed ID: 15956086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
    Gurll NJ; Reynolds DG; Vargish T; Lechner R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):621-4. PubMed ID: 7062272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of naloxone in hemorrhagic shock in pigs.
    Salerno TA; Milne B; Jhamandas KH
    Surg Gynecol Obstet; 1981 Jun; 152(6):773-6. PubMed ID: 7244952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cardiovascular reactions to simulated hypovolaemia, modified by the opiate antagonist naloxone.
    Foldager N; Bonde-Petersen F
    Eur J Appl Physiol Occup Physiol; 1988; 57(4):507-13. PubMed ID: 3396565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone does not influence cardiovascular responses to mild mental stress in postmenopausal women.
    Litschauer B; Schaller G; Wolzt M
    Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2120-5. PubMed ID: 15994852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers.
    Duranteau J; Pussard E; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1995 Nov; 40(5):431-8. PubMed ID: 8703646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone improves arterial blood pressure and hypoxic ventilatory depression, but not survival, of rats during acute hypoxia.
    Endoh H; Honda T; Ohashi S; Shimoji K
    Crit Care Med; 2001 Mar; 29(3):623-7. PubMed ID: 11373431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting central hypovolemia in simulated hypovolemic shock by automated feature extraction with principal component analysis.
    van der Ster BJP; Westerhof BE; Stok WJ; van Lieshout JJ
    Physiol Rep; 2018 Nov; 6(22):e13895. PubMed ID: 30488597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naloxone on stress-induced analgesia after hemorrhagic shock.
    Fukuda T; Nishimoto C; Toyooka H
    Reg Anesth Pain Med; 2005; 30(4):339-43. PubMed ID: 16032585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced defense of central blood volume during acute lower body negative pressure-induced hypovolemic circulatory stress in aging women.
    Lindenberger M; Länne T
    Shock; 2012 Jun; 37(6):579-85. PubMed ID: 22592634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flosequinan does not affect systemic and regional vascular responses to simulated orthostatic stress in healthy volunteers.
    Duranteau J; Pussard E; Edouard A; Samii K; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1992 Sep; 34(3):207-14. PubMed ID: 1389945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of mild central hypovolemia with furosemide administration vs. lower body suction on dynamic cerebral autoregulation.
    Ogawa Y; Aoki K; Kato J; Iwasaki K
    J Appl Physiol (1985); 2013 Jan; 114(2):211-6. PubMed ID: 23195631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone inhibits not only stress-induced analgesia but also sympathetic activation and baroreceptor-reflex sensitivity.
    Fechir M; Breimhorst M; Kritzmann S; Geber C; Schlereth T; Baier B; Birklein F
    Eur J Pain; 2012 Jan; 16(1):82-92. PubMed ID: 21745755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.